Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123142045> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2123142045 endingPage "300" @default.
- W2123142045 startingPage "291" @default.
- W2123142045 abstract "We have developed an intensive combination chemotherapy regimen for the treatment of patients with poor risk nonseminomatous testicular cancer. This regimen (termed PVeBV) consists of cisplatin [P] (at twice the dose used in previous combination chemotherapy regimens), vinblastine [Ve], bleomycin [B], and VP-16 [V]. Cisplatin was administered in hypertonic saline with vigorous chlorouresis. In a pilot study we demonstrated that PVeBV was an active regimen in high risk patients but associated with severe myelosuppression. Consequently, a clinical trial of PVeBV vs standard PVeB chemotherapy in high risk patients is currently in progress at the Medicine Branch of the National Cancer Institute. Patients eligible for this trial must be previously untreated and have bulky disease either in the abdomen or lungs as well as other poor prognostic features. A preliminary analysis of this trial demonstrates a higher complete remission rate (87%) for PVeBV compared to (62%) for PVeB. There has only been one relapse (4%) in patients randomized to receive PVeBV compared to a 20% relapse rate in patients receiving PVeB. There is no statistically significant increase in survival for patients randomized to PVeBV; however, there is a statistically significant prolongation of disease-free survival in patients receiving the intensive four-drug regimen. The increased toxicity of PVeBV was due primarily to more severe myelosuppression. These results demonstrate that PVeBV chemotherapy can be administered to high risk testicular cancer patients with acceptable toxicity and that the preliminary analysis of a randomized trial suggests that PVeBV may be superior to PVeB in the treatment of these high risk patients." @default.
- W2123142045 created "2016-06-24" @default.
- W2123142045 creator A5075213038 @default.
- W2123142045 date "1987-02-01" @default.
- W2123142045 modified "2023-10-18" @default.
- W2123142045 title "Treatment of poor prognosis germ cell tumours with high dose cisplatin regimens" @default.
- W2123142045 cites W1589143027 @default.
- W2123142045 cites W1934120903 @default.
- W2123142045 cites W2023160068 @default.
- W2123142045 cites W2023496931 @default.
- W2123142045 cites W2024320307 @default.
- W2123142045 cites W2032528970 @default.
- W2123142045 cites W2045803500 @default.
- W2123142045 cites W2052055451 @default.
- W2123142045 cites W2055154319 @default.
- W2123142045 cites W2061295542 @default.
- W2123142045 cites W2079322377 @default.
- W2123142045 cites W2079449139 @default.
- W2123142045 cites W2161043352 @default.
- W2123142045 cites W2401796353 @default.
- W2123142045 cites W2403520188 @default.
- W2123142045 doi "https://doi.org/10.1111/j.1365-2605.1987.tb00196.x" @default.
- W2123142045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2438222" @default.
- W2123142045 hasPublicationYear "1987" @default.
- W2123142045 type Work @default.
- W2123142045 sameAs 2123142045 @default.
- W2123142045 citedByCount "5" @default.
- W2123142045 crossrefType "journal-article" @default.
- W2123142045 hasAuthorship W2123142045A5075213038 @default.
- W2123142045 hasConcept C126322002 @default.
- W2123142045 hasConcept C141071460 @default.
- W2123142045 hasConcept C143998085 @default.
- W2123142045 hasConcept C168563851 @default.
- W2123142045 hasConcept C2776212926 @default.
- W2123142045 hasConcept C2776694085 @default.
- W2123142045 hasConcept C2777132456 @default.
- W2123142045 hasConcept C2778239845 @default.
- W2123142045 hasConcept C2778336483 @default.
- W2123142045 hasConcept C2781413609 @default.
- W2123142045 hasConcept C3019864225 @default.
- W2123142045 hasConcept C71924100 @default.
- W2123142045 hasConceptScore W2123142045C126322002 @default.
- W2123142045 hasConceptScore W2123142045C141071460 @default.
- W2123142045 hasConceptScore W2123142045C143998085 @default.
- W2123142045 hasConceptScore W2123142045C168563851 @default.
- W2123142045 hasConceptScore W2123142045C2776212926 @default.
- W2123142045 hasConceptScore W2123142045C2776694085 @default.
- W2123142045 hasConceptScore W2123142045C2777132456 @default.
- W2123142045 hasConceptScore W2123142045C2778239845 @default.
- W2123142045 hasConceptScore W2123142045C2778336483 @default.
- W2123142045 hasConceptScore W2123142045C2781413609 @default.
- W2123142045 hasConceptScore W2123142045C3019864225 @default.
- W2123142045 hasConceptScore W2123142045C71924100 @default.
- W2123142045 hasIssue "1" @default.
- W2123142045 hasLocation W21231420451 @default.
- W2123142045 hasLocation W21231420452 @default.
- W2123142045 hasOpenAccess W2123142045 @default.
- W2123142045 hasPrimaryLocation W21231420451 @default.
- W2123142045 hasRelatedWork W2005899744 @default.
- W2123142045 hasRelatedWork W2065870674 @default.
- W2123142045 hasRelatedWork W2090073172 @default.
- W2123142045 hasRelatedWork W2123142045 @default.
- W2123142045 hasRelatedWork W2166260475 @default.
- W2123142045 hasRelatedWork W2409534244 @default.
- W2123142045 hasRelatedWork W2412182584 @default.
- W2123142045 hasRelatedWork W2417697013 @default.
- W2123142045 hasRelatedWork W2485059434 @default.
- W2123142045 hasRelatedWork W3134705028 @default.
- W2123142045 hasVolume "10" @default.
- W2123142045 isParatext "false" @default.
- W2123142045 isRetracted "false" @default.
- W2123142045 magId "2123142045" @default.
- W2123142045 workType "article" @default.